CincyTech Presents Airway Therapeutics - Video
CEO Steve Linberg and David Willbrand discuss surfactant use in premature neonates, Airway's intent to reintroduce rhSP-D to one or more marketed surfactants, and the potential market impact.
CEO Steve Linberg and David Willbrand discuss surfactant use in premature neonates, Airway's intent to reintroduce rhSP-D to one or more marketed surfactants, and the potential market impact.